Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Infection and Immunity

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.69.2.1032-1043.2001PMID 11160000PMCID PMC97984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RECIPROCAL EXPRESSION OF INTERFERON y OR INTERLEUKIN 4 DURING THE RESOLUTION OR PROGRESSION OF MURINE LEISHMANIASIS Evidence for Expansion of Distinct Helper T Cell Subsets

  2003cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4‐specific monoclonal antibodies: CD4+ T‐cell depletion is not required

  2000cited by this paper
• Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.

  2000cited by this paper
• Interleukin-12 Gene Transfer Results in CD8-Dependent Regression of Murine CT26 Liver Tumors

  1999cited by this paper
• Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo

  1999cited by this paper
• Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

  1999cited by this paper
• Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.

  1998cited by this paper
• Immunocytokines: a promising approach to cancer immunotherapy.

  1998cited by this paper
• Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.

  1997cited by this paper
• Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs

  1997cited by this paper
• A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.

  1997cited by this paper
• Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.

  1997cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• A novel method for real time quantitative RT-PCR.

  1996cited by this paper
• Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

  1995cited by this paper
• Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice

  1995cited by this paper
• Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.

  1995cited by this paper
• Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis

  1995cited by this paper
• Anti-beta 1 integrin IgG inhibits pulmonary macrometastasis and the size of micrometastases from a murine mammary carcinoma.

  1994cited by this paper
• Phase 1 clinical trial of chimeric monoclonal anti‐CD4 antibody in multiple sclerosis

  1994cited by this paper
• Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the antitumor action of interleukin-2

  1994cited by this paper
• Anti-CD4 therapy in recent-onset IDDM.

  1993cited by this paper
• Age influences recovery of systemic and mucosal immune responses following acute depletion of CD4 T cells.

  1993cited by this paper
• Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.

  1993cited by this paper
• Strain dependence of antibody-mediated protection in murine systemic candidiasis.

  1993cited by this paper
• Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies.

  1993cited by this paper
• Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice

  1992cited by this paper
• Identification of a CD4 binding site on the β2 domain of HLA-DR molecules

  1992cited by this paper
• Altered IFN-gamma and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody.

  1992cited by this paper
• Humanised monoclonal antibody therapy for rheumatoid arthritis.

  1992cited by this paper
• Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

  1992cited by this paper
• In vivo inhibition by a monoclonal antibody to CD4+ T cells of humoral and cellular immunity in sheep.

  1992cited by this paper
• Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells.

  1992cited by this paper
• HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS

  1992cited by this paper
• Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells

  1991cited by this paper
• Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies.

  1991cited by this paper
• Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

  1991cited by this paper
• Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.

  1991cited by this paper
• Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance

  1991cited by this paper
• Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice

  1990influential reference
• A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.

  1990cited by this paper
• Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.

  1989cited by this paper
• Suppression of the humoral response to anti-CD3 mAB by pretreatment with anti-CD4 mAB.

  1989cited by this paper
• Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice

  1989cited by this paper
• Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

  1989cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells.

  1988cited by this paper
• CD4+ helper T cells are required for resistance to a highly metastatic murine tumor

  1987cited by this paper
• Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.

  1987cited by this paper
• An enzyme-linked immunosorbent assay for quantifying adherence of Candida to human vascular endothelium.

  1987cited by this paper
• Interaction between CD4 and class II MHC molecules mediates cell adhesion

  1987cited by this paper
• The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain

  1986cited by this paper
• Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component.

  1986cited by this paper
• Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker.

  1985cited by this paper
• Cell adhesion and experimental metastasis: a study using the B16 malignant melanoma model system.

  1984cited by this paper
• Specific suppression of responses to Leishmania tropica by a cloned T-cell line

  1983cited by this paper
• Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.

  1982cited by this paper

• Food Science of Animal Resources

  2023cites this paper
• Barriers for HIV Cure: The Latent Reservoir

  2018cites this paper
• Host Resistance Assays for Efficacy and Immunotoxicology Safety Evaluations

  2017cites this paper
• Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases

  2014cites this paper
• Host Resistance Assays for Immunotoxicity Testing

  2014cites this paper
• Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.

  2013cites this paper
• Impact of Product Attributes on Preclinical Safety Evaluation

  2013cites this paper
• Effect of Malnutrition on the Expression of Cytokines Involved in Th1 Cell Differentiation

  2013cites this paper
• 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract.

  2013cites this paper
• Malignancy After Renal Transplantation: A Review Of The Literature

  2012cites this paper
• Immunoadjuvant activity of icariin that induces Th1-type antibody in mice

  2012cites this paper
• Th1 immunity induction by ginsenoside Re involves in protection of mice against disseminated candidiasis due to Candida albicans.

  2012cites this paper
• Development of Antibody-Based Therapeutics

  2012cites this paper
• Preclinical Safety Considerations for the Development of Antibody-Based Therapeutics

  2012cites this paper
• Antiarthritic effect of lonicerin on Candida albicans arthritis in mice

  2011cites this paper
• Safety Pharmacology: Similarities and Differences between Small Molecules and Novel Biopharmaceuticals

  2010cites this paper
• Immunotoxicology of Biopharmaceutics

  2010cites this paper
• Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models

  2010cites this paper
• Immunomodulatory Biopharmaceuticals and Risk of Neoplasia

  2010cites this paper
• Host resistance assays including bacterial challenge models.

  2010cites this paper
• Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.

  2009cites this paper
• Preclinical development of monoclonal antibodies

  2009cites this paper
• Rutin has therapeutic effect on septic arthritis caused by Candida albicans.

  2009cites this paper
• Alternative Animal Models for Immunomodulation and Immunotoxicity

  2008cites this paper
• Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans.

  2008cites this paper
• Animal Models of Host Resistance

  2008cites this paper
• Immunoregulatory activity by daucosterol, a beta-sitosterol glycoside, induces protective Th1 immune response against disseminated Candidiasis in mice.

  2007cites this paper
• Preclinical safety testing of monoclonal antibodies: the significance of species relevance

  2007cites this paper
• Influenza virus host resistance model.

  2007cites this paper
• Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.

  2006cites this paper
• Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell.

  2006cites this paper
• Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

  2006cites this paper
• Genetic aspects of immune-mediated adverse drug effects

  2005cites this paper
• Transgenic Rodent Models in Immunotoxicology

  2005cites this paper
• Malignancy in renal transplantation.

  2004cites this paper
• Animal care best practices for regulatory testing.

  2002cites this paper
• Malignancy after renal transplantation.

  2002cites this paper
• Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-κB binding activity and TNF-α secretion of T cells

  2002cites this paper
• Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero

  2002cites this paper
• Title Page

  1970cites this paper